PDL BioPharma - Eyes focused on Evofem

03:58 EDT 15 Aug 2019 | FinanzNachrichten

In June, PDL invested the second and final tranche of $30m ($60m in total) in Evofem, a women's health company that is preparing to submit an NDA for Amphora, a non-hormonal female contraceptive, i...

Original Article: PDL BioPharma - Eyes focused on Evofem


More From BioPortfolio on "PDL BioPharma - Eyes focused on Evofem"

Quick Search

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...